tiprankstipranks
Trending News
More News >
EcoSynthetix Inc. J (TSE:ECO)
TSX:ECO

EcoSynthetix (ECO) AI Stock Analysis

Compare
12 Followers

Top Page

TSE:ECO

EcoSynthetix

(TSX:ECO)

Select Model
Select Model
Select Model
Neutral 53 (OpenAI - 5.2)
Rating:53Neutral
Price Target:
C$3.50
▼(-16.67% Downside)
Action:ReiteratedDate:02/21/26
The score is driven mainly by improving financial performance but held back by still-negative profitability and volatile/negative 2025 cash flow. The earnings call adds support through reported sales growth and customer traction, while technicals are neutral and valuation is constrained by a negative P/E and no provided dividend yield.
Positive Factors
Commercial traction at large customer
Sustained, multi-fold volume growth at a major pulp customer signals real product stickiness and technical fit. A growing run-rate at one account and cited >$50M opportunity indicate scalable revenue potential and a pathway to meaningful, durable sales expansion if replicated.
Conservative balance sheet
Very low leverage provides financial flexibility to fund commercialization and manage cyclical demand without immediate refinancing. Combined with reported cash reserves, the conservative structure reduces bankruptcy risk and supports multi‑quarter execution while profits mature.
Diversified end-market demand
Revenue growth across pulp, tissue, wood composites and personal care reduces single‑market dependency and smooths cyclicality. Structural interest in bio‑based binders across multiple industrial uses supports sustained addressable market growth and cross‑sell opportunities.
Negative Factors
Weak and inconsistent cash generation
Recent negative operating cash flow and slightly negative free cash flow reflect fragile cash conversion despite revenue gains. Persistent weak cash generation raises execution and funding risks, potentially necessitating capital raises that dilute shareholders or restrict strategic investments.
Margin pressure and rising operating costs
Declining gross margin driven by higher manufacturing costs, together with rising SG&A, compresses operating leverage. If cost pressures persist, they can slow progress to consistent profitability and require sustained higher volumes or pricing power to restore durable margin resilience.
Erosion of equity base from ongoing losses
A shrinking equity base from accumulated losses reduces the company’s capital buffer and increases vulnerability to adverse shocks. Continued erosion heightens the probability of dilution, constrained strategic options, and greater scrutiny from lenders or partners over the medium term.

EcoSynthetix (ECO) vs. iShares MSCI Canada ETF (EWC)

EcoSynthetix Business Overview & Revenue Model

Company DescriptionEcoSynthetix Inc., a renewable chemicals company, develops and commercializes bio-based technologies that are used as replacement solutions for synthetic, petrochemical-based adhesives, and other related products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers EcoMer biomonomer for use in pressure sensitive adhesives, ink, toner resins, and paints; EcoSphere biolatex, a bio-based latex binder used in paper and paperboard coatings; EcoStix, a family of sugar-acrylic and pressure-sensitive adhesives, which include customizable resin grades and formulated grades; and DuraBind engineered biopolymers that enable manufacturers of particle board, MDF, veneers, and laminates to decrease the amount of highly regulated chemicals, such as formaldehyde in their formulation. Its products are used in various industries, such as paper and paper board; building materials; adhesives, paints, and coatings; films, recyclable packaging, labels, and stamps; and personal care products. The company was founded in 1996 and is headquartered in Burlington, Canada.
How the Company Makes MoneyEcoSynthetix makes money primarily by selling its bio-based polymer products to industrial customers, with revenue recognized from product shipments under supply agreements and purchase orders. The company’s key revenue streams are: (1) sales of bio-based binders used as replacements for synthetic latex binders in paper and paperboard coating and packaging applications; and (2) sales of strength additives and other functional bio-polymers used by pulp and paper producers to improve product performance (e.g., strength and runnability). Earnings are influenced by customer adoption of its renewable chemistries, pricing and volume under commercial supply relationships, and demand conditions in end markets such as packaging and pulp & paper. Information on specific material partnerships, customer names, or the relative contribution of each product line to revenue is null.

EcoSynthetix Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:May 05, 2026
Earnings Call Sentiment Positive
The call presented a positive outlook with strong sales growth and market diversification, particularly in pulp and tissue markets, as well as progress in wood composites and personal care. However, there were concerns about declining gross profit percentage and increased SG&A expenses. Despite these challenges, the company's strategic market positioning and operational efficiencies indicate a strong potential for future growth.
Q3-2025 Updates
Positive Updates
Sales Growth and Market Diversification
Sales were up 11% year-over-year, driven by strong demand in key end markets such as pulp, tissue, wood composites, and personal care.
Increase in Pulp Market Potential
The demand for strength aids from a global pulp manufacturer increased from approximately $1 million to more than $3 million annually, with potential market opportunities exceeding $50 million at this customer.
New Wins in Tissue Market
Won 2 new tissue accounts during the quarter through a partnership with the R&M Group.
Progress in Wood Composites
Increased demand from a key strategic account, with usage of binders across more SKUs at the first mill and ongoing trials at a second mill.
Positive Momentum in Personal Care
Increased demand from partner Dow, with all-natural formulations gaining traction with smaller brands of top 10 players.
Operational Efficiency Improvements
Internalizing North American production led to productivity improvements and increased cycle time in commercial production and R&D.
Cash Management and Strategic Investment
Managed cash reserves responsibly with $30.4 million in cash and term deposits, investing $1 million to retire shares and increasing working capital.
Negative Updates
Decline in Gross Profit Percentage
Gross profit as a percentage of sales declined to 34.2%, down from 36.8% in the previous year, primarily due to higher manufacturing costs.
Increased SG&A Expenses
SG&A expenses rose to $1.8 million from $1.5 million the previous year, driven by higher salary, benefit costs, and repairs and maintenance.
Decrease in Adjusted EBITDA
Adjusted EBITDA decreased to $200,000 from $360,000 in the same period in 2024, due to higher operating expenses.
Company Guidance
During the EcoSynthetix 2025 Third Quarter Results Conference Call, the company provided several key metrics indicating growth and progress across its core markets. Sales increased by 11% year-over-year, driven by strong demand in pulp, tissue, and wood composites, with volumes in these segments exceeding the overall sales growth rate. The company's gross profit margin was reported at 34.2%, down from 36.8% in the same period in 2024, attributed to higher manufacturing costs due to product mix. Notably, the demand for EcoSynthetix’s SurfLock strength aids from a major global pulp manufacturer increased significantly, with their annual run rate on the first line growing from $1 million to over $3 million. EcoSynthetix also achieved two new tissue account wins during the quarter, partly through their collaboration with the European distributor, R&M Group. In personal care, the company observed an uptick in demand from its partner Dow, signaling potential growth in this market segment. Financially, net sales for the quarter were $5.8 million, with SG&A expenses rising to $1.8 million and R&D expenses declining to $390,000. Adjusted EBITDA was reported at $200,000 for the quarter, and the company maintained a cash reserve of $30.4 million as of September 30, 2025.

EcoSynthetix Financial Statement Overview

Summary
Revenue and margins have improved materially and the net loss has narrowed, supported by low leverage. However, the company is still not consistently profitable and 2025 saw a pullback to negative operating and free cash flow, which increases execution and funding-risk concerns.
Income Statement
46
Neutral
Revenue has rebounded strongly over the last two years (up to 21.2M in 2025 from 12.7M in 2023), and profitability is improving materially versus prior years (net loss narrowed to -0.44M in 2025 from -2.82M in 2023). Gross margin has also expanded (about 29% in 2025 vs ~22% in 2022–2023). The key weakness is that the business is still not consistently profitable, with negative operating profit and a slightly negative net margin in 2025, indicating the cost structure remains a hurdle despite better top-line performance.
Balance Sheet
78
Positive
The balance sheet looks conservatively financed, with low leverage (debt-to-equity ~0.09 in 2025, and generally very low in prior years) and a sizable equity base relative to assets. This provides resilience and financial flexibility. The main offset is that equity has been gradually trending down over time, consistent with ongoing losses, which can pressure long-term balance sheet strength if profitability does not normalize.
Cash Flow
34
Negative
Cash generation is mixed and recently weakened: operating cash flow fell to slightly negative in 2025 (from +1.10M in 2024), and free cash flow was negative in 2025 (about -0.89M) after turning positive in 2024. While the reported free cash flow relative to net income appears high in 2025, that is largely a function of a very small net loss rather than strong underlying cash conversion. Overall, the company has not shown consistent, repeatable free cash flow, which raises execution and funding-risk concerns if losses persist.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue21.16M18.54M12.66M19.03M18.16M
Gross Profit6.14M5.31M2.78M4.15M3.97M
EBITDA-636.30K-2.02M-3.24M-1.77M-1.86M
Net Income-441.39K-1.37M-2.82M-1.32M-3.12M
Balance Sheet
Total Assets42.65M41.28M42.84M48.19M50.98M
Cash, Cash Equivalents and Short-Term Investments29.53M32.20M33.28M25.86M42.23M
Total Debt2.19M237.79K584.36K819.47K1.08M
Total Liabilities4.13M1.94M1.87M3.14M3.18M
Stockholders Equity38.52M39.35M40.97M45.06M47.80M
Cash Flow
Free Cash Flow-885.09K236.11K-1.31M-5.17M94.09K
Operating Cash Flow-23.96K1.10M316.99K-4.90M474.07K
Investing Cash Flow2.21M3.47M2.00M-31.15M24.69M
Financing Cash Flow-1.72M-1.73M-2.27M-1.51M474.28K

EcoSynthetix Technical Analysis

Technical Analysis Sentiment
Negative
Last Price4.20
Price Trends
50DMA
3.96
Negative
100DMA
4.11
Negative
200DMA
4.13
Negative
Market Momentum
MACD
-0.11
Positive
RSI
37.13
Neutral
STOCH
29.93
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:ECO, the sentiment is Negative. The current price of 4.2 is above the 20-day moving average (MA) of 3.79, above the 50-day MA of 3.96, and above the 200-day MA of 4.13, indicating a bearish trend. The MACD of -0.11 indicates Positive momentum. The RSI at 37.13 is Neutral, neither overbought nor oversold. The STOCH value of 29.93 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:ECO.

EcoSynthetix Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
53
Neutral
C$200.25M-386.59-2.11%30.76%52.23%
53
Neutral
C$177.28M-10.46-2.95%3.12%5.06%93.02%
44
Neutral
C$259.10M-3.44-92.59%6.29%-3.71%
42
Neutral
C$14.36M-2.61-86.94%-15.84%-375.96%
42
Neutral
C$113.58M-4.53-64.59%56.03%
41
Neutral
C$7.97M-6.5491.27%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:ECO
EcoSynthetix
3.39
-1.10
-24.50%
TSE:BOS
Airboss of America
6.53
2.87
78.22%
TSE:CNO
California Nanotechnologies
0.30
-0.31
-50.82%
TSE:NANO
Nano One Materials
0.95
0.35
58.33%
TSE:GMG
Graphene Manufacturing Group Ltd
2.20
1.28
139.13%
TSE:SURE
SureNano Science Ltd
0.24
0.15
193.75%

EcoSynthetix Corporate Events

Business Operations and StrategyStock BuybackFinancial Disclosures
EcoSynthetix Delivers Double-Digit 2025 Growth and Achieves Climate Positive Operations
Positive
Feb 20, 2026

EcoSynthetix reported higher net sales of $5.9 million in the fourth quarter of 2025 and $20.8 million for the full year, representing growth of 9% and 12% respectively, driven by improved product mix and increased volumes in wood composites, pulp, tissue and personal care. Gross profit and adjusted EBITDA also improved, while the company added new SurfLock strength-aid customers in Europe, expanded trials with a major pulp manufacturer, and recorded its highest annual sales across key strategic markets.

The company highlighted that its bio-based technology is gaining traction with major partners, including a personal care collaboration with Dow and a leading wood composites retailer focused on sustainability. EcoSynthetix achieved climate positive operations in 2025 by enabling customers to avoid more than 125% of its associated carbon emissions, maintained a strong cash position of $29.6 million, and continued shareholder returns through share repurchases under its normal course issuer bid.

The most recent analyst rating on (TSE:ECO) stock is a Hold with a C$4.00 price target. To see the full list of analyst forecasts on EcoSynthetix stock, see the TSE:ECO Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 21, 2026